Empire Life Investments Inc. lessened its stake in shares of CME Group Inc (NASDAQ:CME) by 97.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 633 shares of the financial services provider’s stock after selling 28,590 shares during the quarter. Empire Life Investments Inc.’s holdings in CME Group were worth $119,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the company. BlackRock Inc. raised its position in CME Group by 1.8% in the 3rd quarter. BlackRock Inc. now owns 22,422,112 shares of the financial services provider’s stock valued at $3,816,468,000 after purchasing an additional 403,327 shares during the last quarter. Capital International Investors raised its position in CME Group by 18.3% in the 3rd quarter. Capital International Investors now owns 15,425,378 shares of the financial services provider’s stock valued at $2,625,554,000 after purchasing an additional 2,383,280 shares during the last quarter. Capital Research Global Investors raised its position in CME Group by 107.8% in the 3rd quarter. Capital Research Global Investors now owns 10,906,683 shares of the financial services provider’s stock valued at $1,856,427,000 after purchasing an additional 5,658,108 shares during the last quarter. Edgewood Management LLC raised its position in CME Group by 9.5% in the 3rd quarter. Edgewood Management LLC now owns 8,582,518 shares of the financial services provider’s stock valued at $1,460,830,000 after purchasing an additional 742,067 shares during the last quarter. Finally, Janus Henderson Group PLC raised its position in CME Group by 3.3% in the 3rd quarter. Janus Henderson Group PLC now owns 6,331,522 shares of the financial services provider’s stock valued at $1,077,689,000 after purchasing an additional 202,365 shares during the last quarter. Institutional investors and hedge funds own 90.59% of the company’s stock.

Shares of CME Group stock opened at $178.20 on Monday. The firm has a market cap of $60.56 billion, a price-to-earnings ratio of 37.36, a PEG ratio of 2.18 and a beta of 0.30. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.15. CME Group Inc has a one year low of $152.50 and a one year high of $197.08.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Shareholders of record on Friday, March 8th will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a yield of 1.68%. This is an increase from CME Group’s previous quarterly dividend of $0.70. CME Group’s dividend payout ratio is presently 58.70%.

In other news, insider Julie Winkler sold 5,847 shares of the company’s stock in a transaction on Friday, November 16th. The shares were sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the transaction, the insider now directly owns 24,255 shares of the company’s stock, valued at approximately $4,729,967.55. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO John W. Pietrowicz sold 17,960 shares of the company’s stock in a transaction on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the transaction, the chief financial officer now directly owns 44,780 shares in the company, valued at $8,370,277.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 52,494 shares of company stock valued at $9,967,852. 0.43% of the stock is owned by insiders.

Several analysts recently commented on CME shares. Bank of America reiterated a “buy” rating and issued a $200.00 price target on shares of CME Group in a research report on Monday, November 5th. Berenberg Bank upgraded shares of CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target for the company in a research report on Tuesday, November 20th. Atlantic Securities started coverage on shares of CME Group in a research report on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 price target for the company. Barclays began coverage on shares of CME Group in a research report on Tuesday, December 4th. They issued an “overweight” rating and a $210.00 price target for the company. Finally, Jefferies Financial Group restated a “buy” rating and set a $204.00 price objective on shares of CME Group in a research report on Wednesday, January 9th. Nine analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and an average target price of $195.21.

WARNING: This piece was originally published by Watch List News and is owned by of Watch List News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The correct version of this piece can be read at https://www.watchlistnews.com/cme-group-inc-cme-stake-decreased-by-empire-life-investments-inc/2812111.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Featured Story: What is Depreciation?

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.